Internal Medicine, Infectious Disease · Pensacola, FL
NPI
1083697320
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2120 E Johnson Ave
Pensacola, FL, 32514
Phone (850) 549-4755
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
242,970 services
Medicare patients, 2024
2,051
Average age 77
Drug cost, 2024
$887K
2,705 prescriptions
Company payments, 2025
$700
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pardeep Kumari was code J0878 (injection, daptomycin, 1 mg), 59,900 times for 17 patients. In total Pardeep Kumari billed 242,970 services in 65 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 59,900 | 17 | $0.04 | $2,564 |
| J0872 Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg | Office | 54,501 | 15 | $0.15 | $8,205 |
| J2185 Injection, meropenem, 100 mg | Office | 18,117 | 93 | $0.29 | $5,283 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 8,196 | 303 | $0.52 | $4,229 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 7,190 | 81 | $0.36 | $2,565 |
| J3370 Injection, vancomycin hcl, 500 mg | Office | 5,519 | 136 | $1.76 | $9,695 |
| 96365 Intravenous Infusion, Hydration | Office | 4,840 | 317 | $50.64 | $245K |
| 99309 SNF E&M | Facility | 4,270 | 740 | $89.85 | $384K |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 4,235 | 58 | $1.00 | $4,230 |
| 99232 Hospital E&M - Subsequent | Facility | 3,896 | 580 | $65.98 | $257K |
| J0713 Injection, ceftazidime, per 500 mg | Office | 3,522 | 29 | $1.29 | $4,542 |
| 96521 Chemotherapy | Office | 3,234 | 192 | $99.84 | $323K |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 2,978 | 31 | $0.62 | $1,852 |
| 99214 Office E&M - Established | Office | 2,896 | 550 | $105.96 | $307K |
| 96375 Injection Administration | Office | 2,026 | 152 | $12.51 | $25K |
By year: 2022 $2.0M for 212,871 services; 2023 $2.5M for 225,600 services; 2024 $2.8M for 242,970 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pardeep Kumari prescribed most often to Medicare patients was Vancomycin Hcl, with 315 prescriptions and refills. In total Pardeep Kumari wrote 2,705 Medicare prescriptions that cost $887K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 315 | 315 | 96 | $39K |
| Sodium Chloride 0.9 % Sodium Chloride | 258 | 258 | 71 | $4,668 |
| Meropenem Generic | 202 | 202 | 61 | $20K |
| Doxycycline Hyclate Generic | 165 | 175 | 104 | $3,054 |
| Cefepime Hcl Generic | 113 | 113 | 43 | $21K |
| Ceftriaxone Ceftriaxone Sodium | 108 | 108 | 46 | $5,994 |
| Fluconazole Generic | 100 | 101 | 59 | $874 |
| Daptomycin Generic | 88 | 88 | 21 | $41K |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 84 | 84 | 11 | $12K |
| Cephalexin Generic | 79 | 82 | 52 | $1,201 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 63 | 63 | 19 | $6,866 |
| Cefazolin Sodium Generic | 61 | 61 | 16 | $4,287 |
| Rifampin Generic | 59 | 77 | 16 | $4,027 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 59 | 59 | 34 | $415 |
| Ciprofloxacin Hcl Generic | 55 | 59 | 39 | $805 |
Brand drugs: 549 claims; generic drugs: 2,156 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pardeep Kumari $700 ($700 in general payments such as food, travel and fees) from 8 companies. The largest payer was Insmed, Inc. with $290.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.